BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 2, 2026
Home » Topics » Disease categories and therapies » Orthopedics

Orthopedics
Orthopedics RSS Feed RSS

BioWorld MedTech’s Orthopedics Extra for Jan. 13, 2021

Jan. 13, 2021
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: New treatment allows some people with spinal cord injury to regain hand and arm function; Scientists reveal how gut microbes can influence bone strength in mice; New drug form may help treat osteoporosis, calcium-related disorders; Hip fracture incidence expected to increase substantially in some Eurasian countries.
Read More
Illustration of osteomyelitis

Locate Bio granted FDA breakthrough device designation for resorbable bone graft

Jan. 8, 2021
By Annette Boyle
Cognitoss, a resorbable bone graft in development by Locate Bio Ltd., received U.S. FDA breakthrough device designation for treating chronic osteomyelitis, a progressive, inflammatory bone infection. The graft uses a new class of composite collagen product combined with a dual-phasic release of antibiotics to prevent reinfection.
Read More

BioWorld MedTech’s Orthopedics Extra for Jan. 6, 2021

Jan. 6, 2021
By Liz Hollis
Keeping you up to date on recent developments in orthopedics, including: Discovery of aging mechanism for hematopoietic stem cells; Long-term study finds dozens of new genetic markers associated with lifetime bone growth; Living alone may increase risk of dying after hip fracture; Bone fracture risk may increase when critical enzymatic processes decline.
Read More
3D printing illustration

Solvay partners with Printerprezz to develop 3D printing solutions for medical devices

Jan. 4, 2021
By Bernard Banga
PARIS – Solvay SA is partnering with Printerprezz Inc. to develop 3D printing technology using Selective Laser Sintering (SLS) for implants and other medical devices.
Read More

BioWorld MedTech’s Orthopedics Extra for Dec. 30, 2020

Dec. 30, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: What’s the ‘true’ rate of dislocation after total hip replacement?; A human gene placed in fruit flies reveals details about a human developmental disorder; Life expectancy and health care costs for patients with rheumatoid arthritis.
Read More

BioWorld MedTech’s Orthopedics Extra for Dec. 23, 2020

Dec. 23, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Remote monitoring leads to fourfold decline in returns to hospital after joint surgery; Researchers identify rare genetic bone disorder through massive sequencing methods; Orthogrid Systems says data support the use of its technology for orthopedic surgery; Exercise may protect bone health after weight loss surgery.
Read More
Illustration showing the Bridge-Enhanced ACL Repair (BEAR) implant process

FDA grants de novo approval of first new treatment for ACL tears in 30 years

Dec. 22, 2020
By Annette Boyle
Miach Orthopaedics Inc. got a leg up on competitors with the U.S. FDA's de novo approval of its Bridge-Enhanced ACL Repair (BEAR) implant. The company achieved a long-term goal in orthopedics, developing a graft-free system that enables the anterior cruciate ligament (ACL) to repair itself. The device represents the first new treatment for ACL tears in three decades.
Read More

With its Jazz platform approved, Implanet aims to conquer the Mexican market

Dec. 21, 2020
By Sergio Held
CAJICA, Colombia – After a lengthy process, French spinal-cord implants manufacturer Implanet SA received marketing authorization by Cofepris, the Mexican health care surveillance agency, to distribute its Jazz platform in the Latin American country. Martillac, France-based Implanet is now looking to train surgeons in Mexico to use its Jazz platform that is designed to improve the treatment of spinal pathologies requiring vertebral fusion surgery.
Read More
M&A cityscape

Integra Lifesciences inks deal to buy Acell for up to $400M

Dec. 16, 2020
By Liz Hollis
Integra Lifesciences Holdings Corp. has entered a definitive agreement to acquire regenerative medicine-focused Acell Inc. for an up-front cash payment of $300 million and up to an additional $100 million upon the achievement of certain revenue growth milestones. The deal is expected to close in the first quarter of 2021, subject to the satisfaction of customary conditions. It also comes almost three months after London-based Smith+Nephew plc said it was going to pick up the extremity orthopedics business of Integra for $240 million in cash.
Read More

BioWorld MedTech’s Orthopedics Extra for Dec. 16, 2020

Dec. 16, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: HSS bone study sheds light on complications after spinal surgery; Simplify Medical reports first implant of its cervical artificial disc in the U.S. following FDA 1-Level approval; Scientists say xenon improves properties of maxillofacial and orthopedic implants.
Read More
Previous 1 2 … 15 16 17 18 19 20 21 22 23 … 29 30 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • Vials, syringes, and pills

    With improved technologies, biomarkers, failed drugs may come into their own

    BioWorld
    At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Amyloid beta peptides on neurons

    Amlogenyx’s AM-805 reduces amyloid plaques in AD

    BioWorld Science
    The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing